longitudin
studi
investig
chang
erythrocyt
complement
receptor
express
patient
sever
acut
respiratori
syndrom
sar
circul
express
semiquantifi
flow
cytometr
analys
sar
patient
healthi
individu
control
sinc
express
influenc
genet
polymorph
gene
major
genet
polymorph
locat
within
intron
gene
simultan
analys
polymeras
chain
reaction
pcr
restrict
fragment
length
polymorph
rflp
result
show
express
level
refer
net
fluoresc
intens
valu
nfi
statist
correl
relev
genet
genotyp
among
chines
popul
includ
healthi
individu
nfi
hh
hl
genotyp
respect
sar
patient
nfi
hh
hl
genotyp
respect
interestingli
express
densiti
found
fall
significantli
initi
progress
phase
week
diseas
onset
gradual
return
close
normal
whole
convalesc
phase
begin
week
week
sar
patient
irrespect
genotyp
conclus
find
least
suggest
like
involv
immun
pathogenesi
sar
diseas
sever
acut
respiratori
syndrom
sar
new
emerg
diseas
caus
novel
coronaviru
sarscov
belong
famili
coronavirida
worldwid
outbreak
catastroph
sar
epidem
sar
diseas
affect
cumul
number
subject
claim
death
record
world
health
organ
clinic
sar
character
persist
high
fever
temperatur
c
nonproduct
cough
dyspnoea
rapidli
progress
abnorm
result
radiographi
laboratori
evid
sarscov
rna
exist
specif
antibodi
sar
subject
exhibit
typic
cours
acut
selflimit
ill
around
die
sar
diseas
associ
complic
date
consider
find
earli
clinic
manifest
haematolog
radiolog
microbilog
aspect
show
sarscov
infect
result
sever
cytopath
chang
histolog
patholog
lung
patient
autopsi
clinic
manifest
abnorm
show
chest
radiograph
suggest
chang
like
induc
acut
overwhelm
immun
respons
vivo
underli
mechan
process
sarscov
infect
poorli
understood
yet
recent
studi
indic
complement
receptor
one
receptor
refer
molecul
express
erythrocyt
e
vari
much
among
healthi
individu
gene
highli
polymorph
singl
nucleotid
polymorph
snp
site
may
contribut
variat
express
interestingli
wilson
et
al
identifi
genom
hind
iii
restrict
fragment
length
polymorph
rflp
intron
gene
probabl
act
principl
genet
polymorph
found
correl
express
caucasian
give
rise
three
genotyp
includ
homozygos
hh
high
allel
heterozygos
hl
allel
homozygos
low
allel
genet
regul
high
intermedi
low
express
respect
e
bind
complement
opson
microb
pathogen
immun
complex
ic
surfac
molecul
deliv
tissu
macrophag
fix
reticuloendotheli
system
elimin
result
e
function
one
multipl
compon
host
innat
immun
play
crucial
role
invad
pathogen
e
lose
age
circul
particular
process
markedli
acceler
patient
varieti
inflammatori
diseas
character
chronic
viral
infect
hiv
hcv
lepromat
leprosi
specif
autoimmun
diseas
like
system
lupu
erythematosu
sle
suggest
molecul
like
particip
pathogenesi
immunecomplex
mediat
diseas
beij
affect
area
sar
epidem
earli
claim
case
death
viral
infect
may
produc
variou
haematolog
chang
previou
work
find
motiv
us
seek
molecul
peripher
blood
chang
patient
sarscov
infect
address
question
longitudin
record
alter
circul
express
throughout
cours
sar
ill
sar
patient
addit
simultan
analys
distribut
hind
iii
express
polymorph
gene
among
sar
patient
healthi
individu
find
suggest
molecul
one
import
compon
innat
immun
involv
process
deadli
sar
diseas
employ
confirm
sar
patient
male
femal
age
rang
year
age
rang
year
admit
beij
hospit
period
march
june
patient
fulfil
accept
definit
sar
briefli
incub
period
patient
within
rang
day
earli
prodrom
period
patient
fever
c
h
nonproduct
cough
short
breath
new
pulmonari
infiltr
chest
radiographi
highresolut
ct
scan
absenc
alter
diagnosi
explain
clinic
present
patient
nurs
isol
ward
sar
patient
studi
protocol
approv
ethic
committe
institut
written
inform
consent
obtain
particip
fresh
edtaanticoagul
peripher
blood
ml
obtain
sarsdiagnos
patient
enrol
weekli
interv
genom
dna
sampl
extract
ml
whole
peripher
blood
use
qiagen
dna
purif
kit
qiagen
ca
usa
previou
report
remain
blood
use
analys
flow
cytometri
simultan
recruit
healthi
subject
receiv
health
examin
hospit
period
enrol
sar
patient
healthi
individu
exclud
hiv
hbv
hcv
infect
well
free
diseas
influenza
pneumonia
differ
sar
randomli
select
sexand
agedmatch
healthi
individu
control
establish
refer
valu
nfi
sar
patient
healthi
subject
chines
han
ethnic
origin
genom
dna
sampl
use
pcr
templat
studi
synthes
pcr
primer
previous
report
cornillet
et
al
primer
primer
cccttgtaaggcaagtctgg
locat
upstream
end
intron
contain
cleavag
site
iii
full
length
amplifi
product
kb
cdna
fragment
size
genotyp
determin
basi
fragment
size
hind
iii
digest
pcr
product
homozyg
hh
individu
exhibit
one
fragment
kb
heterozygot
hl
show
three
fragment
kb
kb
kb
respect
mutant
homozyg
two
band
kb
kb
size
shown
fig
three
differ
genotyp
repres
high
intermedi
low
express
level
respect
analysi
express
use
flow
cytometr
assay
accord
previou
report
express
semiquantit
determin
use
flow
cytometr
analysi
sar
patient
healthi
individu
weekli
possibl
briefli
edtaanticoagul
venou
blood
suspend
phosphatebuff
salin
pb
layer
onto
ficollhypaqu
gradient
solut
centrifug
g
min
erythrocyt
gentli
collect
bottom
layer
wash
three
time
salin
cell
suspend
l
pb
plu
bovin
serum
albumin
bsa
incub
h
c
l
fluorescein
isothiocyan
fitc
conjug
mous
monoclon
antihuman
antibodi
clone
mous
bdpharmingen
bectondickson
mountain
view
ca
control
l
mous
purifi
isotyp
antibodi
conjug
fitc
pb
substitut
antibodi
sampl
wash
fix
pb
contain
bsa
formaldehyd
final
sampl
subject
immunofluoresc
analysi
duplic
facscalibur
bectondickson
mountain
view
ca
usa
within
h
fixat
mean
fluoresc
intens
mfi
stain
erythrocyt
mfi
control
mfic
measur
use
cellquest
softwar
program
becton
dickinson
degre
express
estim
ratio
mfi
mfic
mfismfic
express
net
fluoresc
intens
nfi
accord
previou
report
confirm
reproduc
measur
fluoresc
intens
fitcconjug
calibrit
bead
measur
fac
analysi
everi
time
separ
day
coeffici
varianc
mfi
calibrit
bead
within
method
describ
previou
report
brief
rna
directli
extract
plasma
use
qiaamp
viral
rna
mini
kit
qiagen
hilden
germani
accord
manufactur
instruct
viral
rna
amplifi
nest
reversetranscript
polymeras
chain
reaction
rtpcr
product
analys
electrophoresi
agros
gel
contain
gml
ethidium
bromid
viral
sequenc
confirm
dna
sequenc
analysi
time
plasma
antisarscov
igg
antibodi
detect
accord
instruct
commerci
avail
enzymelink
immunosorb
assay
elisa
kit
huadajibiai
biotech
beij
indirect
assay
employ
kit
use
cultureobtain
sarscov
antigen
captur
antibodi
od
valu
judg
posit
routin
analysi
urin
faec
sampl
complet
differenti
blood
count
includ
total
leucocyt
granulocyt
lymphocyt
monocyt
erythrocyt
haemoglobin
platelet
sar
patient
simultan
record
respect
order
identifi
abnorm
chang
occur
lung
patient
underw
examin
chest
radiographi
daili
patient
progress
diseas
stage
critic
sar
statu
everi
day
patient
stabl
gener
diseas
statu
accord
recent
report
retrospect
calcul
mean
chest
radiograph
score
refer
mcr
score
repres
sever
pneumonia
sar
patient
basi
averag
percentag
area
manifest
ground
glass
opacif
consolid
nodular
shadow
lung
maxim
score
equival
area
involv
patient
receiv
ribavirin
steroid
combin
therapi
rabavirin
broadspectrum
antivir
agent
empir
use
treat
sar
although
efficaci
sure
emerg
outbreak
sar
permit
physician
conduct
random
control
trial
treatment
sar
also
basi
earli
anecdot
experi
radiolog
resembl
acut
respiratori
distress
syndrom
immunolog
mediat
lung
diseas
differ
corticosteroid
regimen
also
employ
treatment
sar
time
commenc
corticosteroid
ribavirin
therapi
vari
individu
patient
differ
steroid
regimen
employ
clinic
sar
patient
therapeut
dose
methylprednisolon
includ
mgday
mgday
mgday
intraven
day
base
clinic
manifest
radiograph
deterior
decreas
high
fever
ventil
patient
distribut
differ
allel
genotyp
among
healthi
subject
sar
patient
analys
use
pearson
c
test
statist
differ
densiti
e
two
group
compar
use
softwar
program
test
valu
p
repres
statist
differ
distribut
hind
iii
polymorph
analys
use
pcrrflp
sar
patient
healthi
subject
tabl
percentag
hh
hl
genotyp
sar
patient
healthi
subject
respect
h
l
allel
frequenc
group
consist
hardyweinberg
equilibrium
statist
analysi
show
signific
differ
healthi
control
sar
patient
p
therefor
find
suggest
molecul
unlik
direct
influenc
host
genet
suscept
sarscov
infect
enter
target
cell
viral
replic
admiss
unit
observ
patient
high
fever
c
mild
sever
progress
consolid
chang
serial
chest
radiograph
one
side
lung
use
flow
cytometr
analysi
semiquantit
measur
express
level
sar
patient
nfi
valu
fluoresc
densiti
use
indirectli
indic
rel
express
level
figur
show
repres
differ
fluoresc
densiti
repres
healthi
individu
sar
patient
hh
genotyp
sampl
sar
individu
mfi
mfic
respect
thu
nfi
valu
fluoresc
densiti
sar
patient
determin
way
nfi
valu
healthi
individu
determin
result
summar
tabl
show
measur
use
flow
cytometr
analysi
stabl
reproduc
data
tabl
seem
support
follow
notion
hh
hl
genotyp
express
polymorph
correl
high
intermedi
compar
data
two
group
sar
patient
healthi
subject
p
comparison
hh
genotyp
hl
genotyp
among
healthi
subject
p
among
sar
patient
p
healthi
subject
sar
patient
hh
genotyp
p
hl
genotyp
p
clinic
signific
decreas
averag
nfi
valu
fluoresc
densiti
sar
patient
compar
found
healthi
subject
p
even
though
individu
hh
hl
genotyp
howev
except
differ
found
healthi
control
sar
case
genotyp
may
due
small
sampl
size
one
two
subject
present
group
compar
magnitud
decreas
express
level
among
sar
patient
critic
gener
statu
found
critic
sar
patient
exhibit
lower
averag
nfi
valu
compar
found
gener
sar
patient
day
onset
ill
versu
p
hh
genotyp
versu
p
hl
genotyp
tabl
even
though
number
enrol
sar
patient
differ
group
shown
tabl
limit
observ
least
part
suggest
magnitud
decreas
consist
sever
sar
diseas
relat
lung
damag
progress
chang
shown
chest
radiograph
examin
among
patient
case
surviv
diseas
hospit
day
averag
hospit
durat
day
howev
patient
male
year
old
respect
critic
succumb
diseas
due
develop
acut
respiratori
distress
syndrom
ard
aspergillosi
previous
report
result
mortal
rate
even
though
patient
die
identifi
hh
genotyp
dramat
declin
level
express
compar
healthi
subject
hh
genotyp
nfi
versu
addit
patient
also
older
year
old
probabl
sever
underli
diseas
like
hypertens
diabet
may
also
contribut
sever
sarscov
infect
quantit
analys
conduct
weekli
patient
entir
period
hospit
progress
convalesc
stage
obtain
profil
circul
molecul
clinic
statu
pneumonia
sever
viral
rna
specif
antibodi
repres
individu
sar
patient
hh
hl
genotyp
serial
analys
combin
entir
durat
diseas
fig
sarscov
rna
specif
antibodi
detect
plasma
patient
analys
coexist
viral
rna
antibodi
uniqu
observ
patient
serum
igg
becam
posit
sampl
within
day
follow
onset
diseas
observ
decreas
fluoresc
densiti
onset
clinic
ill
persist
day
variat
occur
entir
progress
stage
accompani
abnorm
chest
radiograph
appear
sarscov
vivo
lower
level
slowli
start
increas
seventh
eighth
week
ill
chest
radiograph
highresolut
ct
scan
shown
complet
resolut
approxim
three
week
onset
symptom
patient
convalesc
level
return
normal
patient
within
week
onset
ill
analysi
genet
mutat
respons
stabil
express
level
e
distribut
dynam
alter
would
provid
altern
approach
understand
mechan
regul
sever
inflammatori
tissu
damag
pathogenesi
sarscov
infect
current
observ
confirm
signific
correl
hind
iii
rflp
rel
express
chines
han
ethnic
popul
sampl
consist
earlier
report
southern
chines
taiwanes
blood
donor
also
similar
result
found
caucasian
popul
recent
studi
thailand
also
found
correl
hind
iii
rflp
find
support
notion
variat
among
healthi
individu
inherit
regul
differ
hh
hl
genotyp
found
signific
differ
frequenc
hh
hl
genotyp
sar
patient
healthi
subject
chines
han
popul
sampl
limit
data
suggest
subject
similar
suscept
sar
viral
infect
unlik
complement
regulatori
protein
membran
control
protein
mcp
decayacceler
factor
daf
level
may
direct
influenc
abil
viru
enter
human
target
cell
viral
replic
process
differ
declin
level
found
patient
sle
chronic
hiv
hcv
infect
also
patient
malaria
malign
tumour
chronic
diseas
interestingli
also
found
signific
decreas
sar
patient
may
suggest
acquir
defici
host
innat
immun
sarscov
viral
load
may
import
factor
decreas
sinc
earli
rapid
declin
sequenti
persist
lower
level
occur
period
sarscov
posit
detect
patient
plasma
sputum
throat
swab
andor
stool
sampl
way
sar
viral
infect
may
induc
reduct
damag
innat
immun
shown
tabl
fluoresc
intens
valu
molecul
vari
broad
rang
even
partli
overlap
individu
hh
hl
allel
one
possibl
gene
highli
polymorph
larg
number
singl
nucleotid
polymorph
snp
site
may
also
influenc
express
independ
h
l
allel
fluoresc
densiti
valu
vari
wide
rang
definit
genotyp
hh
hl
allel
variou
individu
may
influenc
exist
haplotyp
report
xiang
et
al
find
dramat
decreas
express
sar
diseas
progress
sar
patient
compar
healthi
control
impli
molecul
engag
pathogenesi
sar
probabl
occur
process
form
antibodysar
antigen
complement
immun
complex
time
host
produc
specif
antibodi
sar
antigen
evid
coexist
specif
antibodi
direct
viral
rna
found
patient
support
hypothesi
therefor
aetiolog
reduct
may
associ
remov
immun
complex
ic
tissu
macrophag
proteolyt
cleav
surfac
e
though
underli
mechan
still
unknown
would
like
mention
data
care
interpret
limit
small
sampl
size
group
factor
includ
case
age
steroid
therapi
may
also
influenc
variat
express
sar
patient
differ
steroid
regimen
dose
rang
mg
mg
day
empir
administr
treatment
sar
base
pneumonia
sever
determin
chest
radiograph
examin
addit
unabl
design
random
control
investig
due
rapid
emerg
sar
epidem
noteworthi
despit
clinic
recoveri
pulmonari
damag
resolut
lower
level
still
longitudin
sustain
period
increas
continu
slowli
near
normal
therefor
find
suggest
densiti
undergo
acut
revers
decreas
correl
initi
progress
convalesc
stage
sar
diseas
densiti
molecul
patient
convalesc
stage
increas
alomost
high
level
found
healthi
subject
may
old
erythrocyt
decreas
densiti
molecul
gradual
replac
newli
produc
erythrocyt
normal
densiti
molecul
turn
increas
percentag
erythrocyt
normal
densiti
molecul
total
peripher
popul
contribut
slow
rise
peripher
level
sar
patient
convalesc
stage
fact
reticulocyt
shown
increas
level
compar
cell
circulatori
system
period
time
jm
mould
unpublish
observ
collect
find
show
acut
revers
acquir
reduct
may
repres
signific
alter
sar
diseas
suggest
molecul
may
one
import
compon
host
innat
immun
probabl
particip
process
deadli
sar
diseas
knowledg
continu
increas
understand
immun
pathogenesi
sar
